Morgan Stanley
OSCR icon

Morgan Stanley’s Oscar Health OSCR Stock Holding History

Morgan Stanley’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3M Sell
2,114,280
-1,240,701
-37% -$26.7M ﹤0.01% 2041
2026
Q1 		$38.5M Sell
3,354,981
-3,459,065
-51% -$48.7M ﹤0.01% 2361
2025
Q4 		$97.9M Buy
6,814,046
+2,043,758
+43% +$35.4M 0.01% 1468
2025
Q3 		$90.3M Buy
4,770,288
+2,035,761
+74% +$33.5M 0.01% 1488
2025
Q2 		$58.6M Buy
2,734,527
+1,719,212
+169% +$25.6M ﹤0.01% 1780
2025
Q1 		$13.3M Sell
1,015,315
-150,872
-13% -$2.24M ﹤0.01% 3085
2024
Q4 		$15.7M Sell
1,166,187
-375,760
-24% -$6.05M ﹤0.01% 2992
2024
Q3 		$32.7M Sell
1,541,947
-73,142
-5% -$1.32M ﹤0.01% 2280
2024
Q2 		$25.6M Sell
1,615,089
-953,832
-37% -$17.5M ﹤0.01% 2398
2024
Q1 		$38.2M Buy
2,568,921
+808,537
+46% +$11.1M ﹤0.01% 2018
2023
Q4 		$16.1M Buy
1,760,384
+850,605
+93% +$5.87M ﹤0.01% 2902
2023
Q3 		$5.07M Sell
909,779
-84,488
-8% -$591K ﹤0.01% 3729
2023
Q2 		$8.01M Buy
994,267
+417,932
+73% +$3.08M ﹤0.01% 3372
2023
Q1 		$3.77M Sell
576,335
-40,617
-7% -$166K ﹤0.01% 4012
2022
Q4 		$1.52M Buy
616,952
+137,073
+29% +$428K ﹤0.01% 4634
2022
Q3 		$2.39M Sell
479,879
-360,237
-43% -$2.1M ﹤0.01% 4296
2022
Q2 		$3.57M Buy
840,116
+58,568
+7% +$373K ﹤0.01% 4061
2022
Q1 		$7.79M Sell
781,548
-596,543
-43% -$4.44M ﹤0.01% 3196
2021
Q4 		$10.8M Sell
1,378,091
-222,113
-14% -$2.79M ﹤0.01% 2870
2021
Q3 		$27.8M Buy
1,600,204
+683,287
+75% +$11.6M ﹤0.01% 1750
2021
Q2 		$19.7M Buy
916,917
+370,639
+68% +$8.87M ﹤0.01% 2159
2021
Q1 		$14.7M Buy
+546,278
New +$17.1M ﹤0.01% 2244

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley's OSCR Position: Q2 2026 in Review

Morgan Stanley reduced its Oscar Health (OSCR) stake by 37% in Q2 2026, selling an estimated $26.7M and leaving 2,114,280 shares worth $60.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

Morgan Stanley first reported a position in OSCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $97.9M in Q4 2025. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Morgan Stanley held 2,114,280 shares of Oscar Health worth $60.3M as of Q2 2026.
  • Morgan Stanley sold 1,240,701 Oscar Health shares in Q2 2026, an estimated $26.7M.
  • Oscar Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2041 holding.
  • Morgan Stanley first reported a position in Oscar Health in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's Oscar Health position peaked at $97.9M in Q4 2025.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.